Results 141 to 150 of about 38,073 (235)

Atypical Autonomic-Predominant Guillain-Barré Syndrome With Pandysautonomia Mimicking Parkinsonism and Recurrent Syncope: A Case Report. [PDF]

Clin Case Rep
Alsaeed R, Rajab Basha N, Thapa S, Li J.
europepmc   +1 more source

Gangliosides in the 21st century: therapeutic prospects for the brain and spine. [PDF]

Front Neurol
Magistretti PJ, Finsterwald C, Itokazu Y, Sipione S, Geisler FH, Filho TB.   +5 more
europepmc   +1 more source

α2-3-sialylated glycosphingolipids in neuroinflammation, immunity, and programmed cell death: mechanistic evidence and context-dependent regulation: a comprehensive review. [PDF]

Front Immunol
Li X, Li L, Liu X, Liu S, Yang W, Gao J, Kang S, Wang L, Li J, Wang X, Du H, Su S, Li Z, Xu W.   +13 more
europepmc   +1 more source

An Optimal Spray Device for the Nose-to-Brain Delivery of AmyP53, an Adaptive Therapeutic Peptide for Alzheimer's and Parkinson's Diseases. [PDF]

Pharmaceutics
Farias G, Chahinian H, Hauchard N, Brunet D, Fantini J, Yahi N, Fantini D, Aulas A.   +7 more
europepmc   +1 more source

Ganglioside [PDF]

, 2020
openaire   +1 more source

Viral triggers of Guillain-Barré syndrome: implications for laboratory diagnostics. [PDF]

Biochem Med (Zagreb)
Kłodnicka K, Januszewski J, Tyczyńska M, Teresińska B, Trzaskacz P, Forma A, Flieger J, Baj J.   +7 more
europepmc   +1 more source

Direct Comparison of MRM-MS and PRM-MS Methods for Quantitative Ganglioside Analysis. [PDF]

J Am Soc Mass Spectrom
Sanni A, Koraich A, Nwaiwu J, Delkhosh AS, Mechref Y.   +4 more
europepmc   +1 more source

Miglustat in Neuronopathic Lysosomal Storage Disorders: Biological Rationale, Clinical Evidence, and Limits of Repurposing. [PDF]

Int J Mol Sci
Lipiński P, Węgrzyn G.
europepmc   +1 more source